Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
SHZ: 300255.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Xiaodong Gao
- Employees
- 1,410
- Headquarters
- Shijiazhuang, China
- IPO year
- 2011
- Market cap
- CN¥42.4B
- Website
- https://www.heparin.cn
Loading 300255…
Loading profile data…Frequently asked questions about 300255
What does Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) do?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium inject...
Where does 300255.SZ trade?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300255.SZ in?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.?
Xiaodong Gao is the chief executive officer of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ).
Where is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. headquartered?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in China.
Does 300255.SZ pay a dividend?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300255.SZ go public?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) completed its initial public offering in 2011.